medline.ch Onkologie

	Diagnostic Value of Spectral CT-Derived Extracellular Volume Fraction in the Early Detection of Sigmoid Colon Metastasis from Bladder Cancer: A Case Report. Surg Case Rep Peng M, Shen L, Song D, Wen L, Xiang Y, Song L. PMID: 42339343 [PubMed - in process]
	Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK. EClinicalMedicine Morgan RD, Porter C, Zhou C, Kristeleit R, Desai S, Vazquez I, George A, Eminowicz G, Walther A, Franklin A, Sadozye AH, Hughes A, Hanna L, Roux R, Lord R, Bowen R, Wood J, Sentamans C, White A, Casbard AC, Humphrys A, Swettenham JB, Nixon LS, Adams R, Ray R, Brogden E, Powell WE, Canham J, Cox TM, Narasimham M, Lowe H, Ensell L, Zubair M, Morris K, Glenister-Doyle M, Gassio AF, Morgan D, Broughton D, Carucci M, Monaghan PJ, Tugwood J, Edmondson RJ, Dive C, Jayson GC, Clamp AR. PMID: 42339309 [PubMed - in process]
	Papillary Renal Neoplasm with Reversed Polarity in a 64-Year-Old Male: A Rare Case Report and Review of the Literature. Int Med Case Rep J Wang Y, Zhang M, Su G, Zhou Q. PMID: 42339132 [PubMed - in process]
	Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study. Front Oncol Lu J, Song X, Zhang C, Zhu Y, Yang H, Li Y. PMID: 42339129 [PubMed - in process]
	Safety and efficacy of cytokine-induced killer cells for gastric cancer: a systematic review and meta-analysis. Front Oncol Zhu M, Yang C, Liang B, Liu Q. PMID: 42339126 [PubMed - in process]
	Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer. Front Oncol Karam MN, Hajj J, Crane CH, Ramia P, Geara F, Hamadeh N, Scott JG, Grobmyer S, Almond R, O'Reilly EM, Hajj C. PMID: 42339120 [PubMed - in process]
	A multi-task deep learning framework for simultaneous prediction of microsatellite instability and tumor mutational burden in gastric cancer from histopathological images. Front Oncol Chang Y, Chang H, Lv Y, Xi S, Yang J, Wang B, Zheng X, Xie Y. PMID: 42339119 [PubMed - in process]
	A systematic review of immune checkpoint inhibitors in endometrial cancer. Front Oncol Zhu N, Zhang C. PMID: 42339113 [PubMed - in process]
	Association between tumor genomic mutations and the risk of PD-1 inhibitor-induced hypophysitis: a retrospective cohort study. Front Endocrinol (Lausanne) Zheng Y, Chen Y, Lin W, Min L. PMID: 42339089 [PubMed - in process]
	S-GRAS score and the complementary prognostic value of neutrophil-to-lymphocyte ratio in adrenocortical carcinoma: evidence for a synergistic interaction. Front Endocrinol (Lausanne) Bényei E, Huszty G, Laki A, Jakab Z, Kiss G, Kovács AK, Borka K, Uhlyarik A, Eitler K, Igaz P, T, Tóth M. PMID: 42339082 [PubMed - in process]
	Effect of the combination of Solanesol from Nicotiana tabacum with calcium hydroxide on tumor necrosis factor-alpha level in human dental pulp stem cells: An in vitro study. J Conserv Dent Endod Widyastuti W, Anggraini W, Fibryanto E, Roeslan MO. PMID: 42339038 [PubMed - in process]
	Hepatocellular Carcinoma Precursor Lesions: From Pathological Basis to Risk Stratification and Precision Intervention. J Hepatocell Carcinoma Yan R, Zhang H, Jiao J, Huang Q, Wang N, Bao J, Li X, Yan S, Li J. PMID: 42339019 [PubMed - in process]
	Blood-Based Inflammatory and Metabolic Biomarkers for Assessing Symptom Burden and Quality of Life in Older Adults with Cancer: A Narrative Review. Ther Clin Risk Manag Lu L, Zhang Y. PMID: 42339016 [PubMed - in process]
	Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study. Front Digit Health Sugawara Y, Kobayashi M, Mannoji E, Saika T, Kado Y, Yamazaki M, Takebe T, Higuchi H. PMID: 42339002 [PubMed - in process]
	BUB1 in cancer genetics and oncogenomics: from chromosomal instability to therapeutic vulnerabilities. Front Genet Wang S, Liu S, Zhou Y, Wang H, Chen J. PMID: 42338979 [PubMed - in process]
	Exploring the molecular link between arecoline exposure and prostate cancer-related alterations: integrative evidence from network toxicology, single-cell transcriptomics, molecular simulation, and experimental validation. Front Pharmacol Zhu X, Liu H, Zeng Z, Zou L, Zhou Y, Zhou T. PMID: 42338969 [PubMed - in process]
	Lymphocyte CD4/CD8 ratio predicts early immune-related toxicity in lung cancer patients treated with immune checkpoint inhibitors: a single-center retrospective study. Front Med (Lausanne) Jin W, Zhao Y, Lv Y, Yao Y, Su X. PMID: 42338947 [PubMed - in process]
	Reprogramming Metabolism and Immunity: Nanotechnology's Promise for Hepatocellular Carcinoma Precision Therapy. Int J Nanomedicine Cheng M, Ni Y, Zhang W, Wu Q. PMID: 42338901 [PubMed - in process]
	Glucan-Based Nanoparticles Empower Precision Cancer Immunotherapy: Design Strategies, Immune Reprogramming Mechanisms, and Clinical Translation Prospects. Int J Nanomedicine Xie Y, Zeng B, Li X, Xu Q, Zhang Y, Sun L, Chang J, Wang Z, Zhu J, Yan X. PMID: 42338900 [PubMed - in process]
	Peptides in the Diagnosis and Treatment of Pancreatic Cancer and Other Pancreatic Diseases from Basic Research to Clinical Translation. Drug Des Devel Ther Gan G, Zhang X, Xu Y, Bai K, Yan X, Dong D, Xiang H, Tao X. PMID: 42338763 [PubMed - in process]

Artikel 1 - 20 / 1946208

Seite 1 von 97311

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung